Nextcure (NXTC) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nextcure is facing a significant risk as it struggles to comply with the Nasdaq Global Select Market’s minimum bid price requirement, risking potential delisting if the compliance is not met by July 30, 2025. The company’s stock has been trading below the required $1.00 per share since December 17, 2024, prompting a deficiency notice from Nasdaq. While an additional compliance period may be granted, failing to meet the standards could result in decreased liquidity, increased volatility, and challenges in raising capital. The company may consider strategies like a reverse stock split to regain compliance, but such actions could further impact stock prices negatively.
The average NXTC stock price target is $3.00, implying 300.00% upside potential.
To learn more about Nextcure’s risk factors, click here.